Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 6226 AL 6240

Lysosomal Channels as New Molecular Targets in the Pharmacological Therapy of Neurodegenerative Diseases via Autophagy Regulation

Tedeschi V, Sapienza S, Ciancio R, Canzoniero LMT, Pannaccione A, Secondo A.

Curr Neuropharmacol. 2025;23(4):375-383. doi: 10.2174/1570159X22666240517101846.

Cholesterol Metabolism in CNS Diseases: The Potential of SREBP2 and LXR as Therapeutic Targets

Wang NQ, Sun PX, Shen QQ, Deng MY.

Mol Neurobiol. 2025 May;62(5):6283-6307. doi: 10.1007/s12035-024-04672-w. Epub 2025 Jan 7.

Modulation of Second Messenger Signaling in the Brain Through PDE4 and PDE5 Inhibition: Therapeutic Implications for Neurological Disorders

Park MK, Yang HW, Woo SY, Kim DY, Son DS, Choi BY, Suh SW.

Cells. 2025 Jan 9;14(2):86. doi: 10.3390/cells14020086.

Flavonoids in the regulation of microglial-mediated neuroinflammation; focus on fisetin, rutin, and quercetin

Jasim MH, Saadoon Abbood R, Sanghvi G, Roopashree R, Uthirapathy S, Kashyap A, Sabarivani A, Ray S, Mustafa YF, Yasin HA.

Exp Cell Res. 2025 Apr 15;447(2):114537. doi: 10.1016/j.yexcr.2025.114537. Epub 2025 Mar 25.

Effectiveness of Lee Silverman Voice Treatment (LSVT)-BIG for Neurological Diseases Other than Parkinson's Disease: Mini Review

Won C, Jang W, Park S.

Brain Sci. 2025 Mar 31;15(4):367. doi: 10.3390/brainsci15040367.

Reversing Epigenetic Dysregulation in Neurodegenerative Diseases: Mechanistic and Therapeutic Considerations

Olawade DB, Rashad I, Egbon E, Teke J, Ovsepian SV, Boussios S.

Int J Mol Sci. 2025 May 21;26(10):4929. doi: 10.3390/ijms26104929.

Repurposing Sigma-1 Receptor-Targeting Drugs for Therapeutic Advances in Neurodegenerative Disorders

Eskandari K, Bélanger SM, Lachance V, Kourrich S.

Pharmaceuticals (Basel). 2025 May 9;18(5):700. doi: 10.3390/ph18050700.

Zebrafish-Based Parkinson's Disease Models: Unveiling Genetic Mechanisms and Therapeutic Pathways

Dodiya R, Sharma P, Israni D, Kamal MA, Greig NH.

CNS Neurol Disord Drug Targets. 2025;24(12):900-920. doi: 10.2174/0118715273367688250528122144.

Unveiling mysteries of aging: the potential of melatonin in preventing neurodegenerative diseases in older adults

Unal O, Akgun-Unal N, Baltaci AK.

Biogerontology. 2025 Jun 24;26(4):125. doi: 10.1007/s10522-025-10254-7.

How does protein aggregate structure affect mechanisms of disaggregation?

Yang Y, Rye HS.

Biochem Soc Trans. 2025 Aug 29;53(4):881-895. doi: 10.1042/BST20253077.

A Perspective on the Role of Mitochondrial Biomolecular Condensates (mtBCs) in Neurodegenerative Diseases and Evolutionary Links to Bacterial BCs

Calcagnile M, Alifano P, Damiano F, Pontieri P, Del Giudice L.

Int J Mol Sci. 2025 Aug 24;26(17):8216. doi: 10.3390/ijms26178216.

Diagnostic Utility of Clinical Neurophysiology in Jerky Movement Disorders: A Review from the MDS Clinical Neurophysiology Study Group

Latorre A, Ganos C, Hamada M, Phielipp N, Rocchi L, Merchant S, Tijssen MA, van der Veen S, Chen R.

Mov Disord Clin Pract. 2025 Mar;12(3):272-284. doi: 10.1002/mdc3.14306. Epub 2024 Dec 18.

An adolescent patient with anti-N-methyl-D-aspartate receptor encephalitis with motor aphasia as the first symptom and complicated by peripheral nerve damage: A case report and literature review

Shen L, Liu H, Liu X, Zhang L, Wang J, Yang N, Yan N.

Medicine (Baltimore). 2025 May 9;104(19):e42436. doi: 10.1097/MD.0000000000042436.

Psychosis and Parkinsonism as the Only Initial Features of SLE in an Elderly Female - A Case Report

Lam MT, Shvueli E, Amlang CJ, Jacoby N, Scheers-Masters J.

Neurohospitalist. 2025 Dec 23:19418744251408879. doi: 10.1177/19418744251408879. Online ahead of print.

Case Report of Pediatric HPCA-Associated Dystonia: Analysis of Ca(2+) and K(+) Channel Dynamics and Experience With Pallidal Deep Brain Stimulation

Nou-Fontanet L, Ousingsawat J, Aziz M, Maroofian R, Karimiani EG, Fernández-López A, Candela-Cantó S, Rumià J, Dominguez AM, Schreiber R, Kunzelmann K, Ortigoza-Escobar JD.

Pediatr Neurol. 2025 Nov;172:46-52. doi: 10.1016/j.pediatrneurol.2025.07.020. Epub 2025 Aug 7.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias